We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDP
RNS Number : 2067N
InnovaDerma PLC
21 October 2016
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.
InnovaDerma PLC ("InnovaDerma" or the "Company")
Issue of Equity
InnovaDerma, a UK developer of 'at-home' and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation, announces that on 20 September 2016, 27,000 Ordinary Shares of EUR0.10 each were allotted at a price of EUR1.00 per Ordinary Share, to an existing shareholder pursuant to an agreement dated 30 June 2016 (the "New Ordinary Shares").
Application will be made to the UK Listing Authority for the New Ordinary Shares, which when issued will rank pari passu with the existing shares in issue, to be admitted to the Official List ("Listing") and application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on its regulated market for listed securities ("Trading"). It is expected that such admission will become effective and the New Ordinary Shares will be issued at 8:00 am on 25 October 2016.
The issue of the New Ordinary Shares is conditional on Listing and Trading as referred to above.
As a result of this allotment, the total number of ordinary shares in issue and the total number of voting rights in the Company is 10,345,535. There are no shares held in treasury.
The above figure of 10,345,535 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Further enquiries:
InnovaDerma PLC Haris Chaudhry/Joe Bayer +61 (0)3 9111 0071 ----------------------------- ----------------------- Sole broker Hybridan LLP +44 (0)203 764 2341 / Claire Noyce/Niall Pearson 2343 ----------------------------- ----------------------- Cardew Group Shan Shan Willenbrock David Roach Emma Ruttle +44 (0)20 7930 0777 ----------------------------- -----------------------
About InnovaDerma:
InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in hair loss, anti-ageing and beauty sectors. InnovaDerma has presence in the United Kingdom, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.
www.innovaderma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEMBBJTMBMTBIF
(END) Dow Jones Newswires
October 21, 2016 09:15 ET (13:15 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions